These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30280766)

  • 1. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR.
    Yu Z; Li N; Jiang K; Zhang N; Yao LL
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5867-5873. PubMed ID: 30280766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway.
    Wang L; Tang B; Han H; Mao D; Chen J; Zeng Y; Xiong M
    Cancer Biother Radiopharm; 2018 Feb; 33(1):32-38. PubMed ID: 29412697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity.
    Su PF; Song SQ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6864-6872. PubMed ID: 30402851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y; Fei Z; Zhu R
    Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.
    Zhao G; Cai C; Yang T; Qiu X; Liao B; Li W; Ji Z; Zhao J; Zhao H; Guo M; Ma Q; Xiao C; Fan Q; Ma B
    PLoS One; 2013; 8(1):e53906. PubMed ID: 23372675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
    Cheng FH; Zhao ZS; Liu WD
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.
    Chen L; Han X; Hu Z; Chen L
    Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells.
    Gao S; Wang K; Wang X
    Neoplasma; 2020 Jul; 67(4):724-734. PubMed ID: 32726125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.
    Zhou Y; Huang Z; Wu S; Zang X; Liu M; Shi J
    J Exp Clin Cancer Res; 2014 Jan; 33(1):12. PubMed ID: 24468065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
    Li G; Cai M; Fu D; Chen K; Sun M; Cai Z; Cheng B
    Cell Physiol Biochem; 2012; 30(6):1481-90. PubMed ID: 23208072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.
    Lin S; Shao NN; Fan L; Ma XC; Pu FF; Shao ZW
    J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):889-895. PubMed ID: 25480586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of microRNA-22 in Suppressing Proliferation and Promoting Sensitivity of Osteosarcoma Cells via Metadherin-mediated Autophagy.
    Wang P; Zhao ZQ; Guo SB; Yang TY; Chang ZQ; Li DH; Zhao W; Wang YX; Sun C; Wang Y; Feng W
    Orthop Surg; 2019 Apr; 11(2):285-293. PubMed ID: 30932352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypeptide LTX-315 reverses the cisplatin chemoresistance of ovarian cancer cells via regulating Beclin-1/PI3K/mTOR signaling pathway.
    Ma J; Liu L; Ling Y; Zheng J
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22853. PubMed ID: 34309113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance.
    Chen Y; Wang L; Zhou J
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2243-2254. PubMed ID: 31411791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Suppression of miR-30a/HMGA2-mediated autophagy in osteosarcoma cells impacts chemotherapeutics-induced apoptosis].
    Xia Q; Ni J; Huang J; Pan B; Yan M; Li W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):757-766. PubMed ID: 31413213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of beclin1 affects the chemotherapeutic sensitivity of osteosarcoma.
    Wu W; Li W; Zhou Y; Zhang C
    Int J Clin Exp Pathol; 2014; 7(10):7114-22. PubMed ID: 25400807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
    Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
    Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S; Wang M; Li Q; Zhu P
    Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.